ClinicalTrials.gg
RecruitingNCT04550117Updated May 29, 2024

Intraspinal Pressure Monitoring for Acute Traumatic Spinal Cord Injury: A Validation Study

An interventional study of Insertion of Intraspinal pressure monitor in Spinal Cord Injuries and Spine Injury, sponsored by University of Manitoba. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-05-29.

Sponsored by University of Manitoba · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Jun 2020; still recruiting 6 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Intraspinal pressure monitoring has been advanced as a potential technique for evaluating spinal cord perfusion after traumatic spinal cord injury. In this study, the investigators aim to validate the technique for insertion of a fiberoptic pressure monitoring device in the subarachnoid space at the site of injury for measurement of intraspinal pressure and spinal cord perfusion pressure. The primary objective of this study is to validate the methodology of invasive intraspinal pressure monitoring to derive parameters for optimal spinal cord perfusion pressure, spinal cord reserve capacity and spinal reactivity index using data obtained during the patient's stay in the intensive care unit.

Secondary objectives of this study will be to a) evaluate the safety of invasive intraspinal pressure monitoring, b) prospectively evaluate the overall relationship between spinal cord perfusion pressure and functional outcomes in patients with acute traumatic spinal cord injury and c) evaluate the relationship between spinal cord perfusion pressure, motor evoked potentials and functional outcomes after incomplete spinal cord injury.

02

Conditions studied

  • Spinal Cord Injuries
  • Spine Injury

Keywords

  • spinal cord perfusion pressure
  • spinal cord injury
  • intraspinal pressure
  • spinal reactivity
03

In context

Spinal Cord Injuries

2,025 studies on the registry are indexed under Spinal Cord Injuries; 537 are open to participants now.

This study's planned enrollment of 20 is below the median of 24 across 1,633 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

University of Manitoba is the lead sponsor of 555 studies on the registry; 89 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • patients with acute traumatic spinal cord injury ASIA A, B or C

      • age between 18-70yrs

Exclusion criteria

Exclusion Criteria:

  • patients with central cord syndrome
  • patients presenting to hospital >48hrs from time of spinal cord injury
  • patients unable to communicate in english language
  • pre-existing cognitive impairment
  • penetrating spinal cord injury
  • pre-existing neurodegenerative disorder involving brain or spinal cord
  • patients with concomitant injuries requiring emergent surgical intervention
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Intraspinal Pressure Monitoring

    A fiberoptic pressure monitoring device will be placed into the subarachnoid space at the site of traumatic spinal cord injury

    Procedure: Insertion of Intraspinal pressure monitor

Interventions

  • ProcedureInsertion of Intraspinal pressure monitor

    A fiberoptic pressure monitoring wire will be placed into the subarachnoid space at the site of traumatic spinal cord injury

06

What researchers measure

Primary outcomes

  1. Derivation of parameters for optimal spinal cord perfusion pressure using intraspinal pressure data

    Derivation of parameters for optimal spinal cord perfusion pressure.

    Time frame: 1 year

Secondary outcomes

  1. Measurement of the accuracy of probe placement in relation to the site of injury

    Time frame: 1 year

  2. Measure the correlation between spinal cord perfusion pressure and the American Spinal Injury Association (ASIA) Impairment scale, Quality of Life Index and Spinal Cord Independence Measure score.

    Time frame: 1 year

  3. Record rates of adverse events in patients having insertion of intraspinal pressure monitor

    Measure infection rates, rates of pseudomeningoceles, neurological injury, probe dislodgment, meningitis and or subdural hematoma at injury site.

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Dhaliwal P, Wilkinson M, Zeiler FA. The Winnipeg Intraspinal Pressure Monitoring Study (WISP): A protocol for validation of fiberoptic pressure monitoring for acute traumatic spinal cord injury. PLoS One. 2022 Sep 20;17(9):e0263499. doi: 10.1371/journal.pone.0263499. eCollection 2022. PubMed 36126069 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04550117
Collaborators
Health Sciences Centre Foundation, Manitoba
Responsible party
Perry Dhaliwal (Assistant Professor of Neurosurgery, University of Manitoba) — Principal investigator
First posted
Sep 16, 2020
Start date
Jun 23, 2020
Primary completion
Oct 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
May 29, 2024

Study contacts

Perry Dhaliwal, MD MPH
Contact
pdhaliwal@exchange.hsc.mb.ca
2047877227
Frederick Zeiler, MD PhD
Contact
frederick.zeiler@umanitoba.ca
2047877227

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion